IGC Pharma (IGC) Short-Term Debt issuances (2016 - 2017)
IGC Pharma has reported Short-Term Debt issuances over the past 8 years, most recently at $76911.0 for Q4 2017.
- Quarterly Short-Term Debt issuances rose 377.04% to $76911.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$448428.0 through Dec 2017, up 15.77% year-over-year, with the annual reading at -$476190.0 for FY2017, 61.98% up from the prior year.
- Short-Term Debt issuances was $76911.0 for Q4 2017 at IGC Pharma, up from -$76911.0 in the prior quarter.
- Over five years, Short-Term Debt issuances peaked at $414321.0 in Q1 2015 and troughed at -$766903.0 in Q3 2015.
- The 5-year median for Short-Term Debt issuances is -$2797.0 (2014), against an average of -$75444.4.
- Year-over-year, Short-Term Debt issuances crashed 25244.36% in 2015 and then surged 377.04% in 2017.
- A 5-year view of Short-Term Debt issuances shows it stood at $101999.0 in 2013, then plummeted by 143.45% to -$44322.0 in 2014, then surged by 148.39% to $21447.0 in 2015, then tumbled by 229.44% to -$27762.0 in 2016, then surged by 377.04% to $76911.0 in 2017.
- Per Business Quant, the three most recent readings for IGC's Short-Term Debt issuances are $76911.0 (Q4 2017), -$76911.0 (Q3 2017), and -$448428.0 (Q1 2017).